KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacira BioSciences (PCRX) Long-Term Deferred Tax (2020 - 2025)

Historic Long-Term Deferred Tax for Pacira BioSciences (PCRX) over the last 6 years, with Q3 2025 value amounting to $120.2 million.

  • Pacira BioSciences' Long-Term Deferred Tax fell 1032.22% to $120.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $120.2 million, marking a year-over-year decrease of 1032.22%. This contributed to the annual value of $130.4 million for FY2024, which is 976.5% down from last year.
  • Latest data reveals that Pacira BioSciences reported Long-Term Deferred Tax of $120.2 million as of Q3 2025, which was down 1032.22% from $128.3 million recorded in Q2 2025.
  • In the past 5 years, Pacira BioSciences' Long-Term Deferred Tax registered a high of $169.3 million during Q1 2022, and its lowest value of $93.3 million during Q3 2021.
  • Moreover, its 5-year median value for Long-Term Deferred Tax was $141.1 million (2024), whereas its average is $138.9 million.
  • As far as peak fluctuations go, Pacira BioSciences' Long-Term Deferred Tax soared by 6952.4% in 2022, and later crashed by 1582.2% in 2024.
  • Pacira BioSciences' Long-Term Deferred Tax (Quarter) stood at $153.4 million in 2021, then grew by 4.53% to $160.3 million in 2022, then dropped by 9.87% to $144.5 million in 2023, then decreased by 9.77% to $130.4 million in 2024, then fell by 7.81% to $120.2 million in 2025.
  • Its Long-Term Deferred Tax stands at $120.2 million for Q3 2025, versus $128.3 million for Q2 2025 and $129.0 million for Q1 2025.